CYP3A5 and tuberculosis: Hence concomitant uses of these drugs exacerbate the incidence of DILI, ii) anti-tuberculosis drugs mainly rifampicin induces CYP2B6 and CYP3A5[27], [28] lowering efavirenz plasma concentration while isoniazid inhibits some CYP enzymes [34].